MKI67 and cancer: All these unfavorable characteristics could have contributed to the worst prognosis of these patients, for whom a 4-fold increased risk of cancer-related death was reported compared with patients with Luminal-A like BC, followed by subgroup 3 (PR<20% and Ki67<20%), and 2 (PR≥20% and Ki67≥20%).